New combo therapy aims to clear hepatitis b and d in 20-patient trial
Disease control
Completed
This early-stage study tested a new treatment approach for adults with chronic hepatitis B or D. Twenty participants received two medications in sequence: P1101 (a type of interferon) followed by an anti-PD1 drug. The main goal was to check safety and tolerability, while also loo…
Phase: PHASE1 • Sponsor: PharmaEssentia • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC